CME and CFTC Clash Over On-Chain Perpetual Futures

The dispute between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission, has escalated into a full-blown battle. The CFTC's decision to allow blockchain-based perpetual futures products has been met with resistance from the CME, which argues that these products are mislabeled and misapplied. The CME claims that futures require an end date, whereas perpetual futures, also known as perps, are designed for traders to take a financial position on an asset's future without any deadlines. The lawsuit filed by the CME argues that these perps are harmful to its long-dated futures products and alleges that the CFTC's sudden embrace of them did not consider the ramifications. The tension between the two entities has been building, particularly since the start of the Iran conflict, which saw a spike in interest in perpetual contracts on oil prices traded on offshore decentralized finance exchanges. The CFTC's reforming agenda has been met with frustration and outrage from some quarters, with critics arguing that the regulator is not considering the potential consequences of its actions. The CME's attempt to fast-track 24/7 trading for crude oil futures was blocked by the CFTC, further fueling the dispute. The CFTC's chairman, Mike Selig, has declined to comment on the matter, while the CME's chairman, Terry Duffy, has argued that the regulator is not following the proper protocol. The definition of a swap is clear, Duffy claims, and when two parties exchange payments, it is deemed a swap. The CFTC's decision to allow perps has been viewed as a threat to the CME's dominance in the derivatives market. The future of CFTC-driven perps remains uncertain as the CME readies its case, which includes claims that the agency rubber-stamped the Kalshi application. The regulatory and tax regimes for swaps and futures are different, and the CME may have the upper hand in this legal dispute. The CFTC's policy statement has opened up the US market for perps, but the lack of a five-member commission has raised concerns about the regulator's approach. The CME's lawsuit has brought attention to the issue, and the outcome of the case will have significant implications for the derivatives market.